DIN 02409682 — APO-VORICONAZOLE 200 MG
APO-VORICONAZOLE is a tablet of Voriconazole marketed by APOTEX INC. The full Voriconazole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02409682
- Brand name
- APO-VORICONAZOLE
- Active ingredient
- Voriconazole
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- DORMANT
- Drug class
- Triazole antifungal agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Voriconazole products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02409674 | APO-VORICONAZOLE | 50 MG | TABLET | APOTEX INC | DORMANT |
| 02525798 | JAMP VORICONAZOLE | 200 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02525771 | JAMP VORICONAZOLE | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02399253 | SANDOZ VORICONAZOLE | 200 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02399245 | SANDOZ VORICONAZOLE | 50 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02256479 | VFEND | 200 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02256487 | VFEND | 200 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02279991 | VFEND | 200 MG | POWDER FOR SUSPENSION | PFIZER CANADA ULC | MARKETED |
| 02256460 | VFEND | 50 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02381966 | VORICONAZOLE FOR INJECTION | 200 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02477696 | VORICONAZOLE FOR INJECTION | 200 MG | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02493829 | VORICONAZOLE FOR INJECTION | 200 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |